We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$100B
AUM Growth
-$5.11B
Cap. Flow
-$9.1B
Cap. Flow %
-9.06%
Top 10 Hldgs %
14.7%
Holding
4,406
New
340
Increased
1,722
Reduced
1,731
Closed
330

Sector Composition

Rank Sector Weight
1 Financials 12.54%
2 Technology 10.18%
3 Healthcare 9.37%
4 Communication Services 6.66%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIVI
3826
DELISTED
Civitas Resources
CIVI
$45K ﹤0.01%
393
-439
-53% -$56.4K
VHI icon
3827
Valhi
VHI
$391M
$45K ﹤0.01%
1,080
+175
+19% +$5.5K
VNCE icon
3828
Vince Holding Corp
VNCE
$80.7M
$44K ﹤0.01%
1,095
-1,468
-57% -$70K
UMC icon
3829
United Microelectronic
UMC
$47.5B
$43K ﹤0.01%
+24,415
New +$44.7K
UUUU icon
3830
Energy Fuels
UUUU
$2.93B
$43K ﹤0.01%
+26,400
New +$39.1K
NADL
3831
DELISTED
North Atlantic Drilling Ltd
NADL
$43K ﹤0.01%
13,687
-57,179
-81% -$173K
FENG
3832
Phoenix New Media
FENG
$17.5M
$41K ﹤0.01%
+2,176
New +$48K
EYPT icon
3833
EyePoint Inc
EYPT
$1.08B
$39K ﹤0.01%
2,279
-315
-12% -$6.38K
ECYT
3834
DELISTED
Endocyte, Inc. Common Stock
ECYT
$39K ﹤0.01%
15,265
-5,915
-28% -$17K
FBIO icon
3835
Fortress Biotech
FBIO
$109M
$38K ﹤0.01%
921
+3
+0.3% +$112
LPCN icon
3836
Lipocine
LPCN
$17.4M
$38K ﹤0.01%
+608
New +$38.5K
CRDF icon
3837
Cardiff Oncology
CRDF
$66.2M
$37K ﹤0.01%
243
+34
+16% +$7.94K
XMAX
3838
XMAX Inc
XMAX
$558M
$37K ﹤0.01%
+766
New +$58.3K
PLUR icon
3839
Pluri
PLUR
$16.8M
$37K ﹤0.01%
321
+8
+3% +$973
NAGE
3840
Niagen Bioscience
NAGE
$264M
$37K ﹤0.01%
11,271
-111
-1% -$302
NM
3841
DELISTED
Navios Maritime Holdings Inc.
NM
$37K ﹤0.01%
2,603
-9,104
-78% -$121K
INFI
3842
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$37K ﹤0.01%
27,252
-222,345
-89% -$290K
ADVM
3843
DELISTED
Adverum Biotechnologies
ADVM
$35K ﹤0.01%
1,198
-267
-18% -$8.73K
MCHX icon
3844
Marchex
MCHX
$78M
$35K ﹤0.01%
13,304
-18
-0.1% -$48
RGLS
3845
DELISTED
Regulus Therapeutics
RGLS
$35K ﹤0.01%
132
-1,160
-90% -$377K
MFIN icon
3846
Medallion Financial
MFIN
$233M
$33K ﹤0.01%
+10,962
New +$39.9K
AGFS
3847
DELISTED
AgroFresh Solutions Inc
AGFS
$33K ﹤0.01%
12,535
-506
-4% -$1.87K
CYTO
3848
DELISTED
Altamira Therapeutics Ltd
CYTO
0
ARCT icon
3849
Arcturus Therapeutics
ARCT
$168M
$29K ﹤0.01%
1,972
-9,999
-84% -$149K
SENS icon
3850
Senseonics Holdings Inc
SENS
$265M
$29K ﹤0.01%
545
-107
-16% -$6.12K

Similar funds

Credit Suisse's Q4 2016 Portfolio in Review

As of Q4 2016, Credit Suisse held 4,406 positions worth $100B, down 4.8% from $106B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse withdrew a net $9.1B in Q4 2016, closing 330 positions and reducing 1,731 holdings. Its most notable exit was ITC HOLDINGS CORP, an estimated $276M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Credit Suisse opened a new position in Howmet Aerospace worth $134M.

  • Credit Suisse's largest Q4 2016 buy was Howmet Aerospace: 9,402,028 shares worth $134M.
  • Credit Suisse added most to Time Warner Inc in Q4 2016, an estimated $581M increase.
  • Credit Suisse's biggest Q4 2016 reduction was Apple, cutting an estimated $626M.
  • Credit Suisse fully exited ITC HOLDINGS CORP in Q4 2016, selling an estimated $276M.
  • Credit Suisse's ten largest holdings make up 15% of its $100B portfolio in Q4 2016.
  • Credit Suisse opened 340 new positions and closed 330 in Q4 2016.
  • Credit Suisse's portfolio value fell 4.8% quarter-over-quarter to $100B.

Based on Credit Suisse's 13F filing for Q4 2016, filed 14 Feb 2017.